Studies in myasthenia gravis. 2. The relation of some clinical and immunological data.
D000293:Adolescent; D000311:Adrenal Glands; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood; D000974:Antibodies, Antinuclear; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003168:Complement Fixation Tests; D003298:Coombs Test; D005260:Female; D005455:Fluorescent Antibody Technique; D005753:Gastric Mucosa; D006801:Humans; D007122:Immunoelectrophoresis; D007223:Infant; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009132:Muscles; D009157:Myasthenia Gravis / Q000097:blood / Q000151:congenital / Q000276:immunology*; D009504:Neutrophils; D012217:Rheumatoid Factor / Q000097:blood; D012699:Serology; D013945:Thymoma / Q000150:complications*; D013950:Thymus Gland; D013961:Thyroid Gland; D005719:gamma-Globulins
D000906:Antibodies; D000974:Antibodies, Antinuclear; D005719:gamma-Globulins; D012217:Rheumatoid Factor